Response from CGB, page-284

Hmm... One thing I strongly suspect is that you did not write this post.

Let's be clear, I am responding to your post out of courtesy. There is nothing that compels me to respond.

If, you believe any of my posts contain factual errors then you may request that the offending post is moderated. That is the HC process as you well know.

"... to the satisfaction of the ASX".

1. As I understand the situation - CGB remains in a state of suspension because they have not yet completed the re-compliance process with the ASX listing rules. If, there has been a change to this, then I may have missed that information and you can show me the countering information.As I understand it, the suspension from the ASX official list supports the conclusion that CGB have not yet satisfied the ASX as to the company's compliance with the relevant listing rules.

I refer you to the announcement of 14 January 2019 (ASX Admission Decision). Has there been an update re the compliance requirements since that date? The approvals (such as they are), as I read that document, were conditional. Therefore, I think that one is entitled to conclude that the ASX is not yet fully satisfied that CGB's is compliant with the relevant listing rules. Yes?

Supporting Material
"The Company’s securities are to be reinstated to official quotation on a date to be decided by ASX but notbefore 25 January 2019, subject to compliance with the conditions as set out in the ASX letter,"  - https://www.asx.com.au/asxpdf/20190114/pdf/441vk4j6t48zwz.pdf

If you are able to show posters any evidence where CGB are now in a position to claim that they are compliant with the listing rules that have prevented the lifting of the current suspension - then I will happily withdraw my statement.

2. CGB has not completed the acquisition of Medcan as noted in the first prospectus. Is that not accurate?

"As previously announced, QBL has entered into an agreement to acquire 100% of Medcan"

https://docs.wixstatic.com/ugd/2e2ae5_52cf73741a1743a4ab87f57f36645dda.pdf



What I noted in my post is based on CGB announcements and the prospectuses (all 12 of them)!  Chiefly, there is this, it clearly states,

"The Board of Queensland Bauxite Limited (ASX: QBL, the “Company”) is excited to announce that theCompany and its subsidiary, Medical Cannabis Limited (“MCL”) have entered into a legally binding heads ofagreement to acquire a 100% interest in Medcan Australia Pty Ltd (“Medcan”) ("Medcan HOA")." 

Subsequent to this 'transforming' document, has CGB acquired 100% of Medcan? I thought that had changed.

 https://docs.wixstatic.com/ugd/1943b6_21612a478ae8446abfe0cd58520c5021.pdf

This has not occurred has it?

And as for, "This is why holders are having to vote again."  As I understand the situation - eligible shareholders are being asked to vote again on the prospectus because the information noted in the first prospectus has changed materially from that which is now being proposed  by the company (e.g. the change in the Medcan deal)

Is that not correct? 

Irrespective, and as I have noted on many occasions, I am more than willing to be proven wrong. My understanding of the facts may well be erroneous. I accept that possibility. However, on that basis, I would be pleased to be directed to any document that counters anything that I have noted.

Perhaps, you could highlight exactly where - I would appreciate that!

If, I have presented something as fact that is not fact, then please show me where that has occurred and I will withdraw that comment.

Thanks